Addition of PegIFN Alfa-2a to CHB Patients Treated With Nucleot(s)Ides
Clinical trial NCT02644538 · UNKNOWN
Trial details
- NCT number
- NCT02644538
- Sponsor
- The Second Affiliated Hospital of Chongqing Medical University
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-01
- Primary completion
- 2017-12-01
- Enrollment
- 196
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.